Lexicon Pharmaceuticals
Home
Contact Us
Site Map
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Patents
Academic Access
Technology Licensing
Scientific Publications
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
04/23/2002
Lexicon Genetics Discovers New Oncogene for the Development of Drugs to Treat Cancer; Broad Therapeutic Pipeline Now Contains 11 Drug Discovery Programs
03/27/2002
Lexicon Genetics Announces Webcast of Presentation at Banc of America Securities Healthcare Conference
03/07/2002
Lexicon Genetics Reports 2001 Fourth Quarter and Full Year Financial Results
02/28/2002
Lexicon Genetics Announces Conference Call to Discuss Year 2001 Financial Results
02/21/2002
Lexicon Genetics Discovers Target for the Development of Drugs to Treat Heart Disease
02/14/2002
Lexicon Genetics Announces Audio Webcast of Presentation at BIO CEO & Investor Conference
01/07/2002
Lexicon Genetics Discovers Drug Target for Potential Treatment of Depression; Gene Knockout Increases Activity and Mobility
01/03/2002
Lexicon Genetics Names Stephen J. McAndrew, Ph.D., Vice President Of Pharmaceutical Business Development
01/02/2002
Lexicon Genetics Announces Webcast of Presentation at JP Morgan H&Q Healthcare Conference
12/04/2001
Lexicon Genetics Advances Gene Target for Inflammation and Organ Transplant Rejection
«
Start
Prev
31
32
33
34
35
36
37
38
39
40
Next
End
»
Page 32 of 41
